🚀 VC round data is live in beta, check it out!
- Public Comps
- Sotera Health
Sotera Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sotera Health and similar public comparables like Stevanato Group, Snibe, Genscript Biotech, Diasorin and more.
Sotera Health Overview
About Sotera Health
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
Founded
2015
HQ

Employees
3.0K
Website
Financials (LTM)
EV
$7B
Sotera Health Financials
Sotera Health reported last 12-month revenue of $1B and EBITDA of $606M.
In the same LTM period, Sotera Health generated $695M in gross profit, $606M in EBITDA, and $256M in net income.
Revenue (LTM)
Sotera Health P&L
In the most recent fiscal year, Sotera Health reported revenue of $1B and EBITDA of $594M.
Sotera Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $695M | XXX | $646M | XXX | XXX | XXX |
| Gross Margin | 59% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | $606M | XXX | $594M | XXX | XXX | XXX |
| EBITDA Margin | 51% | XXX | 51% | XXX | XXX | XXX |
| EBIT Margin | 43% | XXX | 44% | XXX | XXX | XXX |
| Net Profit | $256M | XXX | $245M | XXX | XXX | XXX |
| Net Margin | 22% | XXX | 21% | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sotera Health Stock Performance
Sotera Health has current market cap of $5B, and enterprise value of $7B.
Market Cap Evolution
Sotera Health's stock price is $16.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $7B | $5B | 0.0% | XXX | XXX | XXX | $0.86 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSotera Health Valuation Multiples
Sotera Health trades at 5.5x EV/Revenue multiple, and 10.8x EV/EBITDA.
EV / Revenue (LTM)
Sotera Health Financial Valuation Multiples
As of April 19, 2026, Sotera Health has market cap of $5B and EV of $7B.
Equity research analysts estimate Sotera Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sotera Health has a P/E ratio of 18.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5B | XXX | $5B | XXX | XXX | XXX |
| EV (current) | $7B | XXX | $7B | XXX | XXX | XXX |
| EV/Revenue | 5.5x | XXX | 5.7x | XXX | XXX | XXX |
| EV/EBITDA | 10.8x | XXX | 11.1x | XXX | XXX | XXX |
| EV/EBIT | 12.8x | XXX | 12.9x | XXX | XXX | XXX |
| EV/Gross Profit | 9.5x | XXX | 10.2x | XXX | XXX | XXX |
| P/E | 18.2x | XXX | 18.9x | XXX | XXX | XXX |
| EV/FCF | 29.8x | XXX | 30.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sotera Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Sotera Health Margins & Growth Rates
Sotera Health's revenue in the last 12 month grew by 6%.
Sotera Health's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Sotera Health's rule of 40 is 58% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sotera Health's rule of X is 67% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Sotera Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 51% | XXX | 51% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 7% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 58% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 67% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 24% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sotera Health Public Comps
See public comps and valuation multiples for other Laboratory Services and Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sotera Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Stevanato Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Snibe | XXX | XXX | XXX | XXX | XXX | XXX |
| Genscript Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Diasorin | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantor | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sotera Health M&A Activity
Sotera Health acquired XXX companies to date.
Last acquisition by Sotera Health was on XXXXXXXX, XXXXX. Sotera Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sotera Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSotera Health Investment Activity
Sotera Health invested in XXX companies to date.
Sotera Health made its latest investment on XXXXXXXX, XXXXX. Sotera Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sotera Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sotera Health
| When was Sotera Health founded? | Sotera Health was founded in 2015. |
| Where is Sotera Health headquartered? | Sotera Health is headquartered in United States. |
| How many employees does Sotera Health have? | As of today, Sotera Health has over 3K employees. |
| Who is the CEO of Sotera Health? | Sotera Health's CEO is Michael B. Petras. |
| Is Sotera Health publicly listed? | Yes, Sotera Health is a public company listed on Nasdaq. |
| What is the stock symbol of Sotera Health? | Sotera Health trades under SHC ticker. |
| When did Sotera Health go public? | Sotera Health went public in 2020. |
| Who are competitors of Sotera Health? | Sotera Health main competitors are Stevanato Group, Snibe, Genscript Biotech, Diasorin. |
| What is the current market cap of Sotera Health? | Sotera Health's current market cap is $5B. |
| What is the current revenue of Sotera Health? | Sotera Health's last 12 months revenue is $1B. |
| What is the current revenue growth of Sotera Health? | Sotera Health revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Sotera Health? | Current revenue multiple of Sotera Health is 5.5x. |
| Is Sotera Health profitable? | Yes, Sotera Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sotera Health? | Sotera Health's last 12 months EBITDA is $606M. |
| What is Sotera Health's EBITDA margin? | Sotera Health's last 12 months EBITDA margin is 51%. |
| What is the current EV/EBITDA multiple of Sotera Health? | Current EBITDA multiple of Sotera Health is 10.8x. |
| What is the current FCF of Sotera Health? | Sotera Health's last 12 months FCF is $221M. |
| What is Sotera Health's FCF margin? | Sotera Health's last 12 months FCF margin is 19%. |
| What is the current EV/FCF multiple of Sotera Health? | Current FCF multiple of Sotera Health is 29.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.